Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Tsai

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Advances in Pharmacology (San Diego, Calif.)|June 12, 2016
Ultimate Translation: Developing Therapeutics Targeting on N-Methyl-d-Aspartate ReceptorG E Tsai
Harvard Review of Psychiatry|April 29, 1998
A glutamatergic model of ECT-induced memory dysfunctionE Chamberlin, G E Tsai
The New England Journal of Medicine|April 13, 1995
Nitric oxide-induced motor neuron disease in a patient with alcoholismG E Tsai, D R Gastfriend
The Journal of Neuropsychiatry and Clinical Neurosciences|June 3, 1998
A preliminary study of D-cycloserine treatment in Alzheimer's diseaseG E Tsai, W E Falk, J Gunther
Harvard Review of Psychiatry|September 2, 1999
Functional magnetic resonance imaging of personality switches in a woman with dissociative identity disorderG E Tsai, D Condie, M T Wu, et al.
The American Journal of Psychiatry|March 18, 1999
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatmentG E Tsai, W E Falk, J Gunther, et al.
The American Journal of Psychiatry|June 10, 1998
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawalG E Tsai, P Ragan, R Chang, et al.
The American Journal of Psychiatry|November 30, 1999
D-serine added to clozapine for the treatment of schizophreniaG E Tsai, P Yang, L C Chung, et al.
Molecular Psychiatry|July 17, 2013
Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individualsC-H Lin, H-T Chang, Y-J Chen, et al.
Molecular Psychiatry|December 10, 2008
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behaviorA C Basu, G E Tsai, C-L Ma, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Pharmacology (San Diego, Calif.)|June 12, 2016
Ultimate Translation: Developing Therapeutics Targeting on N-Methyl-d-Aspartate ReceptorG E Tsai
Harvard Review of Psychiatry|April 29, 1998
A glutamatergic model of ECT-induced memory dysfunctionE Chamberlin, G E Tsai
The New England Journal of Medicine|April 13, 1995
Nitric oxide-induced motor neuron disease in a patient with alcoholismG E Tsai, D R Gastfriend
The Journal of Neuropsychiatry and Clinical Neurosciences|June 3, 1998
A preliminary study of D-cycloserine treatment in Alzheimer's diseaseG E Tsai, W E Falk, J Gunther
Harvard Review of Psychiatry|September 2, 1999
Functional magnetic resonance imaging of personality switches in a woman with dissociative identity disorderG E Tsai, D Condie, M T Wu, et al.
The American Journal of Psychiatry|March 18, 1999
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatmentG E Tsai, W E Falk, J Gunther, et al.
The American Journal of Psychiatry|June 10, 1998
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawalG E Tsai, P Ragan, R Chang, et al.
The American Journal of Psychiatry|November 30, 1999
D-serine added to clozapine for the treatment of schizophreniaG E Tsai, P Yang, L C Chung, et al.
Molecular Psychiatry|July 17, 2013
Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individualsC-H Lin, H-T Chang, Y-J Chen, et al.
Molecular Psychiatry|December 10, 2008
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behaviorA C Basu, G E Tsai, C-L Ma, et al.
Pageof 1